6/27/25, 8:22
AM
ADVANCED PHARMACOLOGY NSG 533 EXAM ACTUAL
QUESTIONS AND ANSWERS WITH COMPLETE SOLUTIONS
LATEST RELEASE 2025/2026 GRADED A++
Terms in this set (86)
EP is a 38-year-old Exenatide - Exenatide (Bydureon) once
female patient that weekly has been able to demonstrate
comes in for weight loss and decrease A1C% by 0.7% to
diabetes education 1.2% in clinical trials; however it is
and management. contraindicated for EP due to the self-
She was diagnosed reported history of thyroid cancer.
12 years ago and Dapagliflozin - Dapagliflozin (Farxiga) is
states lately she is contraindicated in this patient due to
not able to control hyperkalemia which could be made
her diet although worse by this drug. The package insert
she continues a does not indicate a specific potassium
1600 calorie diet concentration cut off to no longer use
with appropriate this medication; however, there are
daily carbohydrate better choices in this patient.
intake (per dietitian Sitagliptin - Sitagliptin (Januvia) is able to
prescription) and obtain an A1C goal of less than 7% based
walks 40 minutes on clinical trials and currently the
every day of the patient does not have any cautionary
1/87
,6/27/25, 8:22
AM
week. She states objective measures to not use this
compliance with all medication. DPP-IV inhibitors are weight
medications. She neutral. DPP-IV inhibitors can be used in
denies any history of patients taking sulfonylureas; however,
hypoglycemia it may be recommended to reduce or
despite being able to stop the sulfonylurea dose.
identify signs and Acarbose - Acarbose (Precose) is not
symptoms and recommended for initial management and
describe appropriate is associated with significant GI side
treatment effects. More information would be needed
strategies. regarding fasting and post-prandial
PMH: T2DM, HTN, numbers. In addition, adding acarbose
obesity, depression, would only lower A1c by 0.8% at best and
s/p thyroidectomy therefore would not achieve the desired
due to thyroid A1C goal of <7%
cancer FmHx:
Noncontributory
SHx: (−) Smoking,
alcohol use, past
marijuana use while
in high school
Medications:
Metformin 850 mg
2/87
,6/27/25, 8:22
AM
tid, glipizide 20 mg
bid, lisinopril 20 mg
daily, sertraline 100
mg daily,
multivitamin daily
Vitals: BP 128/82
mg Hg; P 72
beats/min; BMI 31
m/kg2
Laboratory test results:
Na 134 mEq/L, K 5.4
mEq/L, Cl 106 mEq/L,
BUN 16 mg/dL, SCr
0.89 mg/dL, glucose
128 mg/dL; A1C 7.8%
Based on EP's profile
above, which of the
agents would be
able to obtain an
A1C goal of less than
7% and would be
3/87
, 6/27/25, 8:22
AM
appropriate in the
patient? Please
provide an
explanation of
appropriateness or
lack thereof.
4/87
AM
ADVANCED PHARMACOLOGY NSG 533 EXAM ACTUAL
QUESTIONS AND ANSWERS WITH COMPLETE SOLUTIONS
LATEST RELEASE 2025/2026 GRADED A++
Terms in this set (86)
EP is a 38-year-old Exenatide - Exenatide (Bydureon) once
female patient that weekly has been able to demonstrate
comes in for weight loss and decrease A1C% by 0.7% to
diabetes education 1.2% in clinical trials; however it is
and management. contraindicated for EP due to the self-
She was diagnosed reported history of thyroid cancer.
12 years ago and Dapagliflozin - Dapagliflozin (Farxiga) is
states lately she is contraindicated in this patient due to
not able to control hyperkalemia which could be made
her diet although worse by this drug. The package insert
she continues a does not indicate a specific potassium
1600 calorie diet concentration cut off to no longer use
with appropriate this medication; however, there are
daily carbohydrate better choices in this patient.
intake (per dietitian Sitagliptin - Sitagliptin (Januvia) is able to
prescription) and obtain an A1C goal of less than 7% based
walks 40 minutes on clinical trials and currently the
every day of the patient does not have any cautionary
1/87
,6/27/25, 8:22
AM
week. She states objective measures to not use this
compliance with all medication. DPP-IV inhibitors are weight
medications. She neutral. DPP-IV inhibitors can be used in
denies any history of patients taking sulfonylureas; however,
hypoglycemia it may be recommended to reduce or
despite being able to stop the sulfonylurea dose.
identify signs and Acarbose - Acarbose (Precose) is not
symptoms and recommended for initial management and
describe appropriate is associated with significant GI side
treatment effects. More information would be needed
strategies. regarding fasting and post-prandial
PMH: T2DM, HTN, numbers. In addition, adding acarbose
obesity, depression, would only lower A1c by 0.8% at best and
s/p thyroidectomy therefore would not achieve the desired
due to thyroid A1C goal of <7%
cancer FmHx:
Noncontributory
SHx: (−) Smoking,
alcohol use, past
marijuana use while
in high school
Medications:
Metformin 850 mg
2/87
,6/27/25, 8:22
AM
tid, glipizide 20 mg
bid, lisinopril 20 mg
daily, sertraline 100
mg daily,
multivitamin daily
Vitals: BP 128/82
mg Hg; P 72
beats/min; BMI 31
m/kg2
Laboratory test results:
Na 134 mEq/L, K 5.4
mEq/L, Cl 106 mEq/L,
BUN 16 mg/dL, SCr
0.89 mg/dL, glucose
128 mg/dL; A1C 7.8%
Based on EP's profile
above, which of the
agents would be
able to obtain an
A1C goal of less than
7% and would be
3/87
, 6/27/25, 8:22
AM
appropriate in the
patient? Please
provide an
explanation of
appropriateness or
lack thereof.
4/87
